DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Clinical trials for DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS trials appear
Sign up with your email to follow new studies for DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human tests begin for promising new autoimmune disease drug
Disease control Recruiting nowThis early-stage study is testing a new drug called SAR448501 in adults with moderate-to-severe lupus or rheumatoid arthritis who haven't gotten enough relief from their current treatments. The main goal is to find safe dose levels and see how the drug behaves in the body. About …
Matched conditions: DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New drug trial targets Hard-to-Treat skin hardening disease
Disease control Recruiting nowThis study is testing an investigational drug called ianalumab to see if it can help control the progression of diffuse cutaneous systemic sclerosis, a severe form of scleroderma that causes skin thickening and can damage internal organs. About 200 adults with active, early-stage…
Matched conditions: DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
CRISPR breakthrough trial targets incurable autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new treatment called CTX112 for adults with severe autoimmune diseases like lupus, scleroderma, and inflammatory muscle disease that haven't responded to standard therapies. The treatment uses genetically modified immune cells from healthy dono…
Matched conditions: DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Phase: PHASE1 • Sponsor: CRISPR Therapeutics • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC